MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences.

Slides:



Advertisements
Similar presentations
Memorial Sloan-Kettering Cancer Center
Advertisements

Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Diagnosis.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
Imaging modalities in prostate cancer
In the name of God Isfahan medical school Shahnaz Aram MD.
Coding Presented by Allison Tanksley, CPC Robotic Assisted Surgery for the Prostate.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
Prostate Cancer Crisis: Imaging is the Solution Faina Shtern, MD President, AdMeTech Foundation.
BREAST CANCER UPDATE DETECTION TO DIAGNOSIS
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
©2005 Surgical Planning Laboratory, ARR Slide 1 U41: Research resource for Image guided therapy PI: Ferenc Jolesz.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
Maša Radeljak Mentor: A. Žmegač Horvat
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Clinical Utility of Combidex in Various Cancers
©2005 Surgical Planning Laboratory, ARR Slide 1 Magnetic Resonance Therapy: The Prostate program Clare Tempany MD Director, MRT Program leader & Core Leader.
Cancer of middle ear Chunfu Dai M.D & Ph.D. Background Primary tumor in middle cavity Primary tumor in middle cavity Predilection in y Predilection.
Percutaneous CT-Guided Cryotherapy of Renal Masses: Long-term Follow-up and Morbidity. Hussein D. Aoun, M.D Wayne State University / Detroit Medical Center.
Steven M. Larson, M.D. Memorial Sloan Kettering Cancer Center
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!
Case Presentation HKC A 78 y/o man obstructive symptoms Flank pain(_) Gross hematuria(-). LUTS(+)
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
Mark L. Merlin, M.D. Radiotherapy Clinics of Georgia 7/14/2010 The Role of Radiation Therapy in the Management of Prostate Cancer.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
Prostate Cancer Treatment: What’s Best For You?
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
TNM BLADDER CANCER STAGING Dr. Mahnaz Roayaei Radiation Oncologist Assistant Professor Isfahan University of Medical Sciences.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Prostate Cancer Screening Risk Management Ben Inch.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
Performance Characteristics of mpMRI at Centers of Excellence Peter Choyke, MD National Cancer Institute.
Tere Trout Douglas Goodwin Rebecca Loredo David Salonen Richard Siegmann Carlos Henrique Longo Bor-Yau Yang Bhavin Jankharia.
S ARCOMA Diana Marroquin Period 1. W HAT IS SARCOMA ? A type of cancer that develops from certain tissues, like bone or muscle that can spread by extension.
 Introduction  Causes of cancer  Detection  Cancer Treatment Conventional Nanotechnology  Conclusion Contents.
 Introduction  Causes of cancer  Detection  Cancer Treatment Conventional Nanotechnology  Conclusion Contents.
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Utilizing MRI in Prostate Cancer Diagnosis and Fusion Biopsy Ari Goldberg MD,PhD Dept. Radiology Loyola University Medical Center.
JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV.
Manit Arya Consultant Urological Surgeon UCLH and PAH Transforming the Pathway in Prostate Cancer.
SYMPTOMS | DIAGNOSIS | TREATMENT
Don Nguyen1, Sean Li1, Jinxing Yu, MD1
Bladder Cancer and Prostatic Cancer
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Copyright © 2012 American Medical Association. All rights reserved.
As is shown, men treated by radical prostatectomy had a better adjusted survival rate than men without prostate cancer suggesting selection biases for.
An overview of cancer Health 10.
CONVERSATIONS ON PROSTATE CANCER
Staging Cancer.
Advances in the Treatment of Metastatic Prostate Cancer
Oncology Tru Miller White 2.
Supplemental Figure 1: Kaplan-Meier Curves of overall survival based on clinical stage at presentation and treatment modality Kaplan-Meier analyses depicting.
What is New in Hormone Therapy for Prostate Cancer in 2007?
RADICAL PROSTATECTOMY BY; Dr HASSANZADEH
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
LESLIE M. RAINWATER, M.D., WILLIAM R. MORGAN, M.D. 
Treatment Overview: The Multidisciplinary Team
Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.
Prostate Cancer Update
IL6 mRNA is not detected in metastatic prostate cancer cells.
History: 71 yo male post radical prostatectomy 4 years ago for Gleason 4+5 prostate cancer Pre-op staging CT and MDP bone scan were negative for metastatic.
Presentation transcript:

MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences

MR SPECTROSCOPY CHOLINECITRATE

Use of Prostate MRI & MRS Diagnosis of Prostate Ca.Diagnosis of Prostate Ca. Targeting TRUS BiopsyTargeting TRUS Biopsy Local Staging of Prostate Ca.Local Staging of Prostate Ca. Post Radiotherapy Follow-upPost Radiotherapy Follow-up Post Operative Follow-upPost Operative Follow-up

LOCAL STAGING

Stage T2

Stage T3

Stage T4

LYMPH NODE

Targeting for TRUS Guided Bx

Case 4 T2w.

+contract-contract

Spectroscopy

Detection of Prostate Cancer Recurrence after Radiation Therapy

Case 1 T2w.

+contract-contract

Spectroscopy

Case 2 T2w.

+contract-contract

+contract-contract

Spectroscopy

Case 3 T2w.

+contract-contract

Spectroscopy

MRI & MRS in detection of Prostate Cancer Recurrence after Radical Prostatectomy

Prostate Tissue Remnants Tumoral Mass MR Spectroscopy

Case 1 Prostate Tissue Remnants

Case 2 Prostate Tissue Remnants

Case 3 Tumoral Mass

Case 4 Tumoral Mass

Case 5 MR Spectroscopy

Mahyar Ghafoori M.D. The End

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.